Algorhythm Holdings financials
$0.1630+1.94%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $4.4M | $297.0K |
| Gross profit | -$1.3M | -$194.0K |
| Gross margin | −29.9% | −65.3% |
| Operating income | -$7.9M | -$8.4M |
| Net income | -$15.9M | -$23.3M |
| Net margin | −361.4% | −7830.6% |
| Diluted EPS | $-6.41 | $-353.87 |
| EBITDA | -$7.7M | -$4.8M |
| Operating cash flow | -$9.8M | -$9.1M |
| Free cash flow | -$9.9M | -$9.1M |
| Diluted shares | 2.5M | 0.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $1.6M | $7.2M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $9.1M | $50.0K |
| Total assets | $12.7M | $18.3M |
| Total liabilities | $14.6M | $28.8M |
| Shareholders' equity | -$1.9M | -$10.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology